Académique Documents
Professionnel Documents
Culture Documents
Shortened
Recent Stroke Need for Anticoagulants Planned Surgery
DAPT
A Acute
%
JACC 2015; 66:1046-8
EuroIntervention 2015;11:68-74
Bleeding Avoidance Strategies
1. Vascular Access
2. Choice of Stent
3. DAPT Regime
MATRIX
Ø 8404 Patients with ACS & PCI
Ø Randomized to radial vs femoral access
Ø Co-primary endpoints @ 30 days:
- MACE (Death, MI or stroke)
- NACE (MACE + Major Bleeding)
1. Vascular Access
2. Choice of Stent
3. DAPT Regime
Major bleeding in PCI DAPT trials
(first 12 months on DAPT after PCI)
1. Vascular Access
2. Choice of Stent
3. DAPT Medication
Optimal DAPT duration after coronary
stenting?
PCI candidate
A forgotten patient
population
Two-Year Outcomes of
High Bleeding Risk Patients after
Polymer-Free Drug-Coated Stents
Philip Urban, Philippe Garot, Damras Tresukosol,
Stuart J. Pocock, Ian Meredith, Alex Abizaid, Didier Carrié, Christoph
Naber, Andrés Iñiguez, Suneel Talwar,
Ian B.A. Menown, Evald H. Christensen, Samuel Copt,
John Gregson, Hans-Peter Stoll, Samantha Greene,
and Marie-Claude Morice for the LEADERS FREE Investigators
LEADERS FREE Trial Design
Prospective, double-blind randomized (1:1) trial
2466 High bleeding risk (HBR) PCI patients
BioFreedom™ Gazelle™
DCS
vs. BMS
%
12 %
15
9.8% 12.9%
9 12
9 9.4%
6
5.1%
6
3
3
HR 0.71, (95% CI = 0.56‒0.91)
p for superiority < 0.001 p < 0.0001 for non-inferiority
0 HR 0.50, (95% CI = 0.37‒0.69) 0 p = 0.005 for superiority
15.3%
9.2%
5
HR 0.80 (95%CI 0.64-0.99)
p = 0.039
0
0 180 365 545 730 Days
Number at Risk
DCS 1221 1104 1052 1006 620
BMS 1211 1067 1010 973 587
12.0%
10 9.3%
6.8%
5